## Abstract We aimed to investigate whether treatment with levodopa/carbidopa/entacapone when compared with levodopa/carbidopa improves quality of life in Parkinson's disease (PD) patients with no or minimal, nondisabling motor fluctuations. This is a multicenter, randomized, double‐blind study. On
448: Quality of life in early Parkinson’s disease treated with levodopa/carbidopa/entacapone compared to levodopa/carbidopa
✍ Scribed by Victor S.C. Fung
- Book ID
- 116674454
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 58 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0967-5868
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie
## Abstract We compared clinical, pharmacokinetic, and quality‐of‐life measures in patients with Parkinson's disease (PD) who were on standard carbidopa‐levodopa (Std‐L) and after conversion to sustained‐release carbidopa‐levodopa 50/200 (L‐CR). A total of 20 PD patients with motor fluctuations par